VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NVCR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NVCRNovocure Ltd
$13.28$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNVCRBalance Sheet

Novocure Ltd (NVCR) Balance Sheet

13Y historyFree accessUpdated daily

Total debt fell to $231.6M in 3Q26 from $797.9M a year earlier, cutting debt-to-equity to 0.66, yet an accumulated deficit near -$1.4B and a current ratio that compressed from 6.46 to 2.49 suggest the deleveraging warrants scrutiny of its durability.

Income StatementBalance SheetCash FlowRatios

NVCR Balance Sheet

Annual statement

NVCR Balance Sheet

Novocure Ltd (NVCR) balance sheet — 13-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets673.52M646.73M1.11B1.03B1.11B1.07B999.44M439.95M321.37M245.13M261.87M293.9M111.83M183.48M
Cash & Short-Term Investments463.48M457.52M959.87M910.62M969.42M938.51M854.08M328.19M245.88M183.31M219.63M269.42M102.61M175.89M
Cash Only96.73M103.39M163.77M240.82M115.33M209.61M246.17M179.42M140.62M78.59M99.78M119.42M57.61M175.89M
Short-Term Investments366.75M354.13M796.11M669.79M854.1M728.9M607.9M148.77M105.26M104.72M119.85M150M45M0
Accounts Receivable108.26M115.35M102.07M77.11M106.03M97.41M100.47M63.96M36.52M29.57M6.34M003.88M
Days Sales Outstanding58.2164.2461.5655.2671.9566.4574.1866.4553.7460.9627.91--136.75
Inventory40.6M41.11M35.09M38.15M29.38M24.43M27.42M23.7M22.55M22.02M25.55M13.59M3.45M1.89M
Days Inventory Outstanding91.6289.9293.35108.5693.3477.6193.9897.63102.85144.57201.49240.75125.3398.47
Other Current Assets61.17M23.1M2.33M1.74M508K8.47M13.51M21.85M2.13M2.13M267K9.37M4.82M970K
Total Non-Current Assets155.19M157.59M134.21M111.72M80.12M65.97M52.54M39.5M18.42M20.16M20.21M13.43M6.05M5.43M
Property, Plant & Equipment144.09M147M119.59M97.7M68.96M53.88M41.63M34.6M15.37M18.07M18.62M12.58M5.75M5.18M
Fixed Asset Turnover4.99x4.46x5.06x5.21x7.80x9.93x11.87x10.15x16.14x9.80x4.45x2.63x2.69x2.00x
Goodwill00000000000000
Intangible Assets00000000000000
Long-Term Investments00000000000000
Other Non-Current Assets11.1M10.6M14.62M14.02M11.16M12.09M10.91M4.9M3.06M2.1M1.59M851K297K252K
Total Assets828.71M804.33M1.24B1.15B1.19B1.14B1.05B479.45M339.79M265.3M282.08M307.34M117.88M188.91M
Asset Turnover0.90x0.81x0.49x0.44x0.45x0.47x0.47x0.73x0.73x0.67x0.29x0.11x0.13x0.05x
Asset Growth %-147.37%-35.18%8.26%-3.82%4.58%8.32%119.42%41.1%28.08%-5.95%-8.22%160.73%-37.6%-
Total Current Liabilities270.66M223.23M756.38M179.12M158.78M142.6M113.61M86.31M64.56M50.2M36.88M28.63M17.67M15.6M
Accounts Payable145.92M122.23M105.09M94.39M85.2M72.6M53.65M36.92M26.71M17.21M18.36M13.9M10.03M10.29M
Days Payables Outstanding287.96267.35279.6268.57270.72230.67183.86152.11121.78112.93144.76246.26364.89535.35
Short-Term Debt25M11.66M558.16M006.68M6.48M4.63M000000
Deferred Revenue (Current)015.95M14.22M16.22M18.03M17.76M17.77M11.77M8.84M4.96M2.27M000
Other Current Liabilities99.74M9.03M000169K61K64K12.26M5.64M5.58M3.61M1.79M445K
Current Ratio2.49x2.90x1.46x5.78x7.00x7.53x8.80x5.10x4.98x4.88x7.10x10.27x6.33x11.76x
Quick Ratio2.34x2.71x1.42x5.56x6.82x7.36x8.56x4.82x4.63x4.44x6.41x9.79x6.13x11.64x
Cash Conversion Cycle-138.13-113.18-124.69-104.76-105.42-86.61-15.711.9734.892.5984.64---300.13
Total Non-Current Liabilities207.44M240.63M124.23M604.52M591.7M586.4M461.85M175.35M162.97M101.53M102.85M27.89M2.33M1.53M
Long-Term Debt171.34M236.69M97.3M568.82M565.51M562.22M429.9M149.42M149.27M97.34M96.23M23.1M321K346K
Capital Lease Obligations153.87M41.65M19.97M27.42M18.76M13M14.29M14.14M000000
Deferred Tax Liabilities00000000124K0-906K-785K00
Other Non-Current Liabilities882K-37.71M6.96M8.28M4.55M4.71M5.51M3.98M3.65M4.19M6.62M4.79M2.01M1.19M
Total Liabilities478.1M463.86M880.61M783.63M750.48M729M575.46M261.66M227.53M151.73M139.74M56.52M20M17.13M
Total Debt231.55M290M683.35M596.24M584.27M581.9M450.68M168.2M149.27M97.34M96.23M23.1M321K346K
Net Debt134.82M186.61M519.59M355.42M468.94M372.29M204.51M-11.22M8.65M18.75M-3.55M-96.33M-57.29M-175.55M
Debt / Equity0.66x0.85x1.90x1.64x1.32x1.42x0.95x0.77x1.33x0.86x0.68x0.09x0.00x0.00x
Debt / EBITDA-2.15x-----11.39x22.29x------
Net Debt / EBITDA-1.25x-----5.17x-1.49x------
Interest Coverage-15.27x--10.36x-38.41x-9.68x-5.50x1.98x0.34x-1.92x-3.15x-16.55x-36.22x-438.57x-5.08x
Total Equity350.61M340.47M360.18M362.5M441.17M410.49M476.53M217.79M112.26M113.56M142.34M250.82M97.88M171.78M
Equity Growth %-14.63%-5.47%-0.64%-17.83%7.47%-13.86%118.8%94.01%-1.15%-20.22%-43.25%156.27%-43.02%-
Book Value per Share3.003.053.343.414.223.974.382.241.221.281.663.001.3614.27
Total Shareholders' Equity350.61M340.47M360.18M362.5M441.17M410.49M476.53M217.79M112.26M113.56M142.34M250.82M97.88M171.78M
Common Stock00000000000000
Retained Earnings-1.39B-1.29B-1.15B-985.5M-778.46M-685.93M-631.08M-650.88M-643.65M-582.26M-519.93M-388.08M-276.5M-195.82M
Treasury Stock00000000000000
Accumulated OCI-1.59M-3.44M-5.5M-5.47M-2.43M-3.17M-3.83M-2.77M-1.4M-1.34M-1.88M-1.5M-4.28M-2.41M
Minority Interest00000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetMixed
Cash FlowImproving
Top Statement Risk

Leverage reliant on debt refinancing

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Deleveraging Driven by Debt Reduction

Based on NVCR's reported figures, total debt fell from $797.9M in 3Q25 to $231.6M in 3Q26, lowering the debt-to-equity ratio from 2.34 to 0.66 and marking a sharp shift in the balance sheet structure over the period.

The reduction appears to have been driven primarily by debt retirement rather than by equity growth, since shareholders' equity remained within a narrow band of roughly $330M to $362M across all ten quarters. Total liabilities fell alongside debt, which suggests the deleveraging is genuine rather than a reclassification, though the reported figures alone do not reveal how the repayment was funded. Investors should monitor whether the cash position of $96.7M is sufficient to sustain operations if the company continues to post net losses.

Debt Concentration Shifted Toward Lower Leverage

As reported in financial statements, NVCR's debt-to-assets ratio compressed from roughly 0.69 in 3Q25 to about 0.28 in 3Q26, indicating that the company's dependence on borrowed capital has declined materially within the most recent four quarters.

The pattern points to a leverage profile that moved from a potentially strained position toward one that appears more manageable on a reported basis. However, the persistent net losses across every reported quarter mean that debt service must still be met from a cash base that has fluctuated between roughly $93M and $345M. Refinancing risk cannot be fully assessed from these figures, and the maturity profile of remaining obligations warrants further investigation.

Current Ratio Compression Signals Tighter Buffers

Based on NVCR's reported figures, the current ratio declined from 6.46 in 2Q24 to 2.49 in 3Q26, while cash on hand has hovered near $94M to $103M in recent quarters, leaving a narrower buffer than the headline ratio implies.

The current ratio remains well above 1.0, which suggests near-term obligations are covered, but the decline from elevated levels indicates that current liabilities have grown relative to liquid assets over time. Cash holdings have stabilized in a relatively narrow range despite the company's ongoing operating losses, which may point to reliance on operating cash inflows or periodic financing. Investors should watch whether liquidity holds if quarterly revenue growth fails to offset the persistent operating deficit.

Accumulated Deficit Dwarfs Contributed Equity

As reported in financial statements, NVCR carries retained earnings of roughly -$1.4B against total equity of $350.6M, indicating that the cumulative losses absorbed the bulk of paid-in capital over the reporting window.

The gap between the accumulated deficit and equity suggests that equity value rests largely on contributed capital rather than retained profitability, a structure typical of companies still in a growth or clinical-expansion phase. Equity has remained stable at roughly $330M to $360M over ten quarters, implying that losses have been offset by new capital or stock-based issuance rather than eroding the base. Stock-based compensation may be contributing to dilution, a dynamic that warrants monitoring given the scale of the accumulated deficit.

Reported Deleveraging May Mask Refinancing Dependence

Based on reported figures, the sharp fall in debt between 3Q25 and 4Q25 coincided with a cash balance that did not rise commensurately, raising questions about how repayment was financed and whether the apparent balance sheet improvement is fully durable.

Headline leverage metrics have improved substantially, but the reported data does not disclose the source of funds used to retire roughly $500M of debt within two quarters. Cash balances remained near $100M, so the repayment may have relied on undisclosed financing, asset sales, or restructured terms that the supplied data does not capture. Given persistent net losses in every reported quarter, the durability of the improved leverage position cannot be confirmed without further review of the debt agreements and cash flow statements.

NVCR — Frequently Asked Questions

Quick answers to the most common questions about buying NVCR stock.

What are the total assets of Novocure Ltd (NVCR)?

As of 2025, Novocure Ltd (NVCR) had total assets of $804.3M including $646.7M in current assets.

How much debt does Novocure Ltd (NVCR) have?

Novocure Ltd (NVCR) carries total debt of $290.0M, offset by $457.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Novocure Ltd?

Novocure Ltd (NVCR) has total shareholders' equity (book value) of $340.5M ($3.05 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Novocure Ltd's current ratio and liquidity?

Novocure Ltd (NVCR) reported a current ratio of 2.90x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.